CONTACT US
News and Stories About Biomarker Testing
Research Spotlight by Dr. Anna Berkenblit: July 2025
Editor’s note: The “Research Spotlight” series is written by Dr. Anna Berkenblit, PanCAN’s Chief Scientific and Medical Officer. Each month, […]
READ MORE
Continuing the Conversation: Pancreatic Cancer Clinical Trials
PanCAN recently hosted a webinar titled “Clinical Trials: At the Leading Edge of Progress.” Our panel had a wide-ranging conversation […]
READ MORE
Clinical Trials Key Part of Treatment Journey for Pancreatic Cancer Survivor
Pranathi Perati almost cancelled the endoscopy appointment she had scheduled. Antacids seemed to be helping the abdominal discomfort she had […]
READ MORE
Research Spotlight – Pancreatic Cancer: A Look Back at 2024
While pancreatic cancer remains one of the toughest cancers to treat and is predicted to become the second-leading cause of […]
READ MORE
FDA Approves New Targeted Therapy for NRG1 Fusion-Positive Pancreatic Cancer: What You Need to Know
The U.S. Food and Drug Administration has granted accelerated approval for a new drug targeting a tumor alteration called NRG1 […]
READ MORE
Know Your Tumor Uncovers Rare Mutation, Leads to Effective Treatment for Patient
Most mornings, 66-year-old Luis Rios begins his day with movement, whether it’s a walk, light weightlifting or some other physical […]
READ MORE
Precision Medicine: What’s Next? A Q&A with PanCAN Leaders
Pancreatic cancer stands apart as a difficult disease to prevent, diagnose and treat. Of all the major cancers, it is […]
READ MORE
Continuing the Conversation: Pancreatic Cancer Clinical Trials
PanCAN recently hosted a webinar titled “Spotlight on Clinical Trials: A PanCAN Conversation.” Hundreds of patients, caregivers and loved ones […]
READ MORE
Breaking Down Barriers to Pancreatic Cancer Research: Two New Publications Highlight PanCAN’s Work
Through the SPARK health data platform, PanCAN breaks down barriers to pancreatic cancer research by making real-world patient data accessible […]
READ MORE
PanCAN Publishes “Roadmap” for Treating Patients With Pancreatic Cancer
PanCAN’s position statements focus on getting patients on the “Right Track.”
Put Your Health First, Says Six-Year Survivor
Teona Ducre raises awareness and encourages patient self-advocacy.
Six-Year Survivor Finds Purpose, Brings Hope to Others Through Social Media
Crystal Morgan shares her journey through social media with equal doses of humor and wisdom.
Another FDA Treatment Approval Underscores Promise of Precision Medicine
The FDA granted approval for a treatment targeting a genetic alteration called RET fusion.
The Fifth Card, Love
Troy and Jennifer Florence share their “five-card poker hand” for facing pancreatic cancer.
New FDA Treatment Approval Underscores Importance of Biomarker Testing
FDA approves combination of drugs based on specific mutation driving cancer growth.
Taking Charge, Finding Answers
After a successful treatment put her in the national spotlight, Kathy Wilkes urges biomarker testing.
A Pancreatic Cancer Journey to Healing
Biomarker testing pinpointed effective treatment for Joanie Kriens’ pancreatic cancer
Five-Year Pancreatic Cancer Survival Rate Increases to 11%
The one percentage point increase signifies important progress.
Hope, Homework and Allies: Doctor, also a Patient, Advises All Three
Dr. Ira Sharp benefits from clinical trial, gives back as PanCAN volunteer
The Importance of Patient Diversity in Clinical Trials
Patient diversity in clinical trials is key to progress.
